NEW YORK (Reuters Health) – In the Platelet Inhibition and Patient Outcomes (PLATO) trial, ticagrelor and clopidogrel were associated with similar rates of major bleeding, but ticagrelor was…
NEW YORK (Reuters Health) – Ten-year survival rates are high when patients with unfavorable localized prostate cancer are treated with external beam radiotherapy boosted with conformal high-dose-rate brachytherapy,…
NEW YORK (Reuters Health) – Hospital outcomes in patients with an acute coronary syndrome are no different whether they were previously taking an angiotensin-converting enzyme inhibitor or not,…
NEW YORK (Reuters Health) – Patients with systemic vasculitis associated with rheumatoid arthritis respond well to rituximab therapy, French investigators report in Arthritis Care & Research online November…
NEW YORK (Reuters Health) – Among stable patients with persistent total occlusion of the infarct-related artery after myocardial infarction, those who undergo late percutaneous coronary intervention (PCI) fare…
NEW YORK (Reuters Health) – Bone loss in postmenopausal women taking adjuvant letrozole for early breast cancer can be prevented with administration of zoledronic acid, investigators report in…
NEW YORK (Reuters Health) – Statin therapy before and during acute ischemic stroke hospitalization is associated with improved poststroke survival, and going off statin therapy in the hospital…
NEW YORK (Reuters Health) – In the rituximab era, it’s not necessary to administer prophylaxis against central nervous system (CNS) disease in patients with diffuse large B-cell lymphoma…
NEW YORK (Reuters Health) – A retrospective study found that children diagnosed with biliary atresia had elevated direct or conjugated bilirubin levels soon after they were born, researchers…
NEW YORK (Reuters Health) – Contrary to some previous results, intracoronary administration of a bolus of adenosine before elective percutaneous coronary intervention does not reduce periprocedural myocardial necrosis,…